These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6482157)

  • 1. [Therapeutic value of pratsiol and its effect on indicators of central and peripheral hemodynamics in patients with hypertension].
    Erina EV; Panfilov VV; Prokopova TN; D'iakonova EG; Beliakova EV
    Kardiologiia; 1984 Jul; 24(7):52-6. PubMed ID: 6482157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of hypotensive and hemodynamic effects of prazosin in patients with hypertension].
    Ostapiuk FE; Dobrotvorskaia TE; Samofanova MS; Shengeliia RG
    Kardiologiia; 1986 Mar; 26(3):45-9. PubMed ID: 3520086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypotensive effect and tolerability of a short course of treatment with prazosin (pratsiol) and hydralazine (apressin) in a cooperative study of new drugs for the prevention of arterial hypertension].
    Kardiologiia; 1985 Jan; 25(1):23-8. PubMed ID: 3981857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect on the peripheral circulation during treatment of cardiac insufficiency].
    Mukharliamov NM
    Kardiologiia; 1980 Apr; 20(4):9-14. PubMed ID: 6768919
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
    Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
    Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic and regional hemodynamic effects of acute and prolonged treatment with urapidil or prazosin in normotensive and spontaneously hypertensive rats.
    Pegram BL; Kobrin I; Natsume T; Gallo AJ; Frohlich ED
    Am J Med; 1984 Oct; 77(4A):64-73. PubMed ID: 6486158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic long-term effects of prazosin plus tolamolol in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1977 Apr; 4(2):141-5. PubMed ID: 577181
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
    Mehta J; Feldman RL; Nichols WW; Pepine CJ; Conti CR
    Br Heart J; 1980 May; 43(5):556-60. PubMed ID: 7378216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic changes caused by prazocin in patients with uncomplicated arterial hypertension].
    Ban Hayashi E; Meaney E; Rivera JM
    Arch Inst Cardiol Mex; 1983; 53(4):357-62. PubMed ID: 6639214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension.
    Lund-Johansen P
    Postgrad Med; 1975 Nov; Spec No():45-52. PubMed ID: 1197143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congestive cardiomyopathy: therapeutic approach.
    Chatterjee K; Stern L
    Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
    Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
    Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of prazosin on the hemodynamics of the anesthetized dog].
    Komarek J
    Arzneimittelforschung; 1978; 28(12):2228-32. PubMed ID: 582935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of chronic congestive failure with vasodilators (acute trial with prazosin and erythrityl tetranitrate)].
    Tomov I; Kaloianova A; Terzieva L; Nikolov G; Elenkova A
    Vutr Boles; 1982; 21(6):45-50. PubMed ID: 6761964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.
    Rubin SA; Chatterjee K; Gelberg HJ; Ports TA; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Apr; 43(4):810-5. PubMed ID: 425918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Methodology of hemodynamic study of a vasodilator drug (author's transl)].
    Morgant C; Merillon JP; Motte G; Guiomard A; Gourgon R
    Anesth Analg (Paris); 1980; 37(9-10):561-6. PubMed ID: 7469072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
    Greenberg BH; Massie BM
    Circulation; 1980 Jun; 61(6):1212-6. PubMed ID: 7371134
    [No Abstract]   [Full Text] [Related]  

  • 20. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.